TY - JOUR
T1 - A Hot-Segment-Based Approach for the Design of Cross-Amyloid Interaction Surface Mimics as Inhibitors of Amyloid Self-Assembly
AU - Andreetto, Erika
AU - Malideli, Eleni
AU - Yan, Li Mei
AU - Kracklauer, Michael
AU - Farbiarz, Karine
AU - Tatarek-Nossol, Marianna
AU - Rammes, Gerhard
AU - Prade, Elke
AU - Neumüller, Tatjana
AU - Caporale, Andrea
AU - Spanopoulou, Anna
AU - Bakou, Maria
AU - Reif, Bernd
AU - Kapurniotu, Aphrodite
N1 - Publisher Copyright:
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - The design of inhibitors of protein-protein interactions mediating amyloid self-assembly is a major challenge mainly due to the dynamic nature of the involved structures and interfaces. Interactions of amyloidogenic polypeptides with other proteins are important modulators of self-assembly. Here we present a hot-segment-linking approach to design a series of mimics of the IAPP cross-amyloid interaction surface with Aβ (ISMs) as nanomolar inhibitors of amyloidogenesis and cytotoxicity of Aβ, IAPP, or both polypeptides. The nature of the linker determines ISM structure and inhibitory function including both potency and target selectivity. Importantly, ISMs effectively suppress both self- and cross-seeded IAPP self-assembly. Our results provide a novel class of highly potent peptide leads for targeting protein aggregation in Alzheimer's disease, type 2 diabetes, or both diseases and a chemical approach to inhibit amyloid self-assembly and pathogenic interactions of other proteins as well.
AB - The design of inhibitors of protein-protein interactions mediating amyloid self-assembly is a major challenge mainly due to the dynamic nature of the involved structures and interfaces. Interactions of amyloidogenic polypeptides with other proteins are important modulators of self-assembly. Here we present a hot-segment-linking approach to design a series of mimics of the IAPP cross-amyloid interaction surface with Aβ (ISMs) as nanomolar inhibitors of amyloidogenesis and cytotoxicity of Aβ, IAPP, or both polypeptides. The nature of the linker determines ISM structure and inhibitory function including both potency and target selectivity. Importantly, ISMs effectively suppress both self- and cross-seeded IAPP self-assembly. Our results provide a novel class of highly potent peptide leads for targeting protein aggregation in Alzheimer's disease, type 2 diabetes, or both diseases and a chemical approach to inhibit amyloid self-assembly and pathogenic interactions of other proteins as well.
KW - Alzheimer's disease
KW - amyloid inhibitors
KW - islet amyloid polypeptide
KW - protein-protein interactions
KW - β-amyloid peptide
UR - http://www.scopus.com/inward/record.url?scp=84944750360&partnerID=8YFLogxK
U2 - 10.1002/anie.201504973
DO - 10.1002/anie.201504973
M3 - Article
C2 - 26336938
AN - SCOPUS:84944750360
SN - 1433-7851
VL - 54
SP - 13095
EP - 13100
JO - Angewandte Chemie International Edition in English
JF - Angewandte Chemie International Edition in English
IS - 44
ER -